Cited 0 times in Scipus Cited Count

Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS

DC Field Value Language
dc.contributor.authorRoh, HW-
dc.contributor.authorKim, NR-
dc.contributor.authorLee, DG-
dc.contributor.authorCheong, JY-
dc.contributor.authorSeo, SW-
dc.contributor.authorChoi, SH-
dc.contributor.authorKim, EJ-
dc.contributor.authorCho, SH-
dc.contributor.authorKim, BC-
dc.contributor.authorKim, SY-
dc.contributor.authorKim, EY-
dc.contributor.authorChang, J-
dc.contributor.authorLee, SY-
dc.contributor.authorYoon, D-
dc.contributor.authorChoi, JW-
dc.contributor.authorAn, YS-
dc.contributor.authorKang, HY-
dc.contributor.authorShin, H-
dc.contributor.authorPark, B-
dc.contributor.authorSon, SJ-
dc.contributor.authorHong, CH-
dc.date.accessioned2023-02-21T04:33:29Z-
dc.date.available2023-02-21T04:33:29Z-
dc.date.issued2022-
dc.identifier.issn1738-3684-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24638-
dc.description.abstractOBJECTIVE: We aimed to present the study design and baseline cross-sectional participant characteristics of biobank innovations for chronic cerebrovascular disease with Alzheimer's disease study (BICWALZS) participants. METHODS: A total of 1,013 participants were enrolled in BICWALZS from October 2016 to December 2020. All participants underwent clinical assessments, basic blood tests, and standardized neuropsychological tests (n=1,013). We performed brain magnetic resonance imaging (MRI, n=817), brain amyloid positron emission tomography (PET, n=713), single nucleotide polymorphism microarray chip (K-Chip, n=949), locomotor activity assessment (actigraphy, n=200), and patient-derived dermal fibroblast sampling (n=175) on a subset of participants. RESULTS: The mean age was 72.8 years, and 658 (65.0%) were females. Based on clinical assessments, total of 168, 534, 211, 80, and 20 had subjective cognitive decline, mild cognitive impairment (MCI), Alzheimer's dementia, vascular dementia, and other types of dementia or not otherwise specified, respectively. Based on neuroimaging biomarkers and cognition, 199, 159, 78, and 204 were cognitively normal (CN), Alzheimer's disease (AD)-related cognitive impairment, vascular cognitive impairment, and not otherwise specified due to mixed pathology (NOS). Each group exhibited many differences in various clinical, neuropsychological, and neuroimaging results at baseline. Baseline characteristics of BICWALZS participants in the MCI, AD, and vascular dementia groups were generally acceptable and consistent with 26 worldwide dementia cohorts and another independent AD cohort in Korea. CONCLUSION: The BICWALZS is a prospective and longitudinal study assessing various clinical and biomarker characteristics in older adults with cognitive complaints. Details of the recruitment process, methodology, and baseline assessment results are described in this paper.-
dc.language.isoen-
dc.titleBaseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer’s Disease Study: BICWALZS-
dc.typeArticle-
dc.identifier.pmid35042283-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898610-
dc.subject.keywordAlzheimer’s disease-
dc.subject.keywordCohort-
dc.subject.keywordDementia-
dc.subject.keywordMild cognitive impairment-
dc.subject.keywordSubcortical vascular cognitive impairment-
dc.subject.keywordVascular dementia-
dc.contributor.affiliatedAuthorRoh, HW-
dc.contributor.affiliatedAuthorLee, DG-
dc.contributor.affiliatedAuthorCheong, JY-
dc.contributor.affiliatedAuthorKim, EY-
dc.contributor.affiliatedAuthorChang, J-
dc.contributor.affiliatedAuthorLee, SY-
dc.contributor.affiliatedAuthorChoi, JW-
dc.contributor.affiliatedAuthorAn, YS-
dc.contributor.affiliatedAuthorKang, HY-
dc.contributor.affiliatedAuthorPark, B-
dc.contributor.affiliatedAuthorSon, SJ-
dc.contributor.affiliatedAuthorHong, CH-
dc.type.localJournal Papers-
dc.identifier.doi10.30773/pi.2021.0335-
dc.citation.titlePsychiatry investigation-
dc.citation.volume19-
dc.citation.number2-
dc.citation.date2022-
dc.citation.startPage100-
dc.citation.endPage109-
dc.identifier.bibliographicCitationPsychiatry investigation, 19(2). : 100-109, 2022-
dc.identifier.eissn1976-3026-
dc.relation.journalidJ017383684-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Psychiatry & Behavioural Sciences
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Journal Papers > School of Medicine / Graduate School of Medicine > Brain Science
Journal Papers > Research Organization > Institute for Medical Sciences
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
Journal Papers > School of Medicine / Graduate School of Medicine > Nuclear Medicine & Molecular Imaging
Journal Papers > School of Medicine / Graduate School of Medicine > Dermatology
Journal Papers > School of Medicine / Graduate School of Medicine > Biomedical Informatics
Files in This Item:
35042283.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse